AlphaMadera's AlphaVal page computes National Research Corporation's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag NRC as undervalued, fairly valued, or overvalued.

What is National Research Corporation's fair value?

Fair value for NRC is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value NRC?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from NRC's most recent reported fundamentals.

NRC - National Research Corporation

Price: -- --

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate

Trading 18.3% above fair value

Current Price $18.54

Bear Case $12.54 32.4% downside ($12.54 - $18.54) / $18.54 = -32.4% $1.25 × 10x P/E

Fair Value $15.68 15.5% downside ($15.68 - $18.54) / $18.54 = -15.5% $1.25 × 12x P/E

Bull Case $18.81 1.5% upside ($18.81 - $18.54) / $18.54 = 1.5% $1.25 × 15x P/E

Adjust Assumptions

P/E Multiple

12.5x

Adjusted EPS

1.25$

Key Value Driver

Normalized P/E multiple (12x base case)

Implied Market Multiple 14.8x

Plain-Language Summary

Applying a 12x P/E to adjusted EPS of $1.25, the base-case value is $15.68 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 141%. Check what costs are being left out of the adjusted number.

⚠ The company pays out 115% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples